In an unusual effort by a single wealthy investor to keep a medical idea alive, a German billionaire is promising $50 million to Therion Biologics Corp., a small Cambridge company trying to develop the first-ever therapeutic vaccine for cancer. Company officials are scheduled to disclose tomorrow that Hans-Werner Hector, founder of German software giant SAP AG, will offer Therion a fresh influx of cash to push the company through its next two years of development, including a possible application to the Food and Drug Administration for its vaccine next year.

Boston Globe (http://www.boston.com/business/technology/biotechnology/articles/2005/12/26/vaccine_for_cancer_finds_a_patron/)